Initial public offerings scheduled to debut next week
IDEAYA Biosciences - San Francisco, 5 million shares, priced $13-$15, managed by JP Morgan/Citi. Business: Phase 1 biotech developing targeted ...
Friday, May 17, 2019 - 16:33
Published